2004
DOI: 10.1038/nrmicro841
|View full text |Cite
|
Sign up to set email alerts
|

Diagnostics for the developing world

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

2
686
0
5

Year Published

2007
2007
2019
2019

Publication Types

Select...
5
3

Relationship

0
8

Authors

Journals

citations
Cited by 897 publications
(710 citation statements)
references
References 36 publications
2
686
0
5
Order By: Relevance
“…The inexpensive and clean optical glass parts can be laminated into devices with various chamber and fluid transport features. Despite growing interest in developing "lab-ona-chip" devices for inexpensive DNA isolation [2,3] [6] the utility of readily available, unmodified glass surfaces in DNA capture chambers has not been described. Several devices have been designed to miniaturize the sample sizes for micro-PCR analysis [7], and silica based DNA capture surfaces have been engineered with higher binding capacity.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…The inexpensive and clean optical glass parts can be laminated into devices with various chamber and fluid transport features. Despite growing interest in developing "lab-ona-chip" devices for inexpensive DNA isolation [2,3] [6] the utility of readily available, unmodified glass surfaces in DNA capture chambers has not been described. Several devices have been designed to miniaturize the sample sizes for micro-PCR analysis [7], and silica based DNA capture surfaces have been engineered with higher binding capacity.…”
Section: Discussionmentioning
confidence: 99%
“…Such "lab on a chip" devices may help bring the benefits of PCR-based molecular diagnosis to users and point-of-care settings that lack the capacity for standard laboratory-based DNA purification [2] [3]. In such applications there are significant pressures to keep costs low.…”
mentioning
confidence: 99%
“…1 The clinical analyses carried out in developed economies, however, are often not directly applicable in developing economies. This translational problem has two components: i) current analytical systems are too expensive, large, complicated, or dependent on infrastructure to be broadly accessible in developing economies, or practically located in inaccessible regions; 2 and ii) developing economies do not have enough trained medical personnel to distribute the analytical systems to inaccessible regions.…”
Section: Introductionmentioning
confidence: 99%
“…The concentration of protein in urine, for example, can be used to distinguish between different renal diseases: nephrotic syndrome ( There are many portable and quantitative devices for detecting disease. 2,[13][14][15] The platforms for these assays range from pressure-driven 8,14 or centrifugal force-driven microfluidic devices, 16 to "dip-stick" immunochromatographic assays. 8,13,15,17,18 The need remains, however, for more effective systems, and especially for systems designed specifically for the conditions in the developing world.…”
Section: Introductionmentioning
confidence: 99%
“…A detailed TPP describes the minimally acceptable and ideal product characteristics and specifications for target population, performance, specimen type and volume, storage conditions, time to results, nature of results, and other parameters [10,11]. The ASSURED criteria (Affordable, Sensitive, Specific, User-friendly, Rapid and robust, Equipment-free, Delivered to those who need it) [12] set out basic test requirements, but how a test achieves those criteria is dependent on the features included by the manufacturer and their usability in the hands of the intended users. There are limited data available on HIVST prototypes.…”
Section: Introductionmentioning
confidence: 99%